Closer to A Cure: Fighting Cancer
With recent advances in the treatments of blood cancers, UCLA Health and the Leukemia & Lymphoma Society are visiting communities across Southern California to discuss these emerging therapies.
To be announced.
Closer to a Cure Community Lecture Series: Updates in CAR T-Cell Therapies for Blood Cancer Treatment
Chimeric antigen receptor T-cell (CAR T) therapies have demonstrated in a short period of time its potential to expand the cancer care landscape. Participants will learn about CAR T-cell therapy, how it is being utilized in blood cancer treatment, the latest innovations and available clinical trials, and what we can expect in the future.
Advances in Treating Acute Myeloid Leukemia (AML)
Current and new strategies for treating acute myeloid leukemia (AML), including available clinical trials. We will also be addressing concerns in cancer survivorship post-treatment.
Understanding Clinical Trials
This program will address the important role of clinical trials in cancer treatment. We will be discussing what they are, when to consider them in treatment, their safety, and common misconceptions. We will also be discussing resources for navigating clinical trials like the Clinical Trial Support Center available through The Leukemia & Lymphoma Society.
Novel Therapies for Multiple Myeloma
This program we will be discussing the current and new ways of treating multiple myeloma.
New Approaches for Treating Childhood Leukemia and Lymphoma
This program we will be discussing childhood leukemia and lymphoma, looking at the emergence of new strategies for treating these cancers in the pediatric population.
Cancer in a Time of Uncertainty: Managing Anxiety and Fears
Cancer patients, survivors and family members face unique stressors during the COVID-19 pandemic. Please join us as we discuss strategies for managing fears and anxiety in this time of uncertainty.
Caring for Adolescents and Young Adults Diagnosed with Cancer
Adolescents and young adults diagnosed with cancer share unique medical and psychological challenges. Join us at this dynamic panel to hear directly from blood cancer survivors diagnosed during their college years and the UCLA Health doctors and allied health professionals that provide care and support to these patients.
DLBCL and Follicular Lymphomas
UCLA oncologist Monica Mead, MD, for an overview of treatment options for patients diagnosed with diffuse large B-cell lymphoma (DLBCL) and other follicular lymphomas. DLBCL is the most common type of non-Hodgkin lymphoma (NHL) in the US, accounting for about 1 out of every 3 lymphomas.
CAR T- Cell Therapy
UCLA oncologist Joshua Sasine, MD, PhD, talks about the latest advancements in CAR T-cell therapy at UCLA.
UCLA oncologist Sarah Larson, MD, covers the latest treatment options and clinical trials available to patients with myeloma.
Advances in Treatments of Blood Cancers (including Immunotherapy)
UCLA oncologist Herbert Eradat, MD, gives an overview of the latest advancements in immunotherapy and other treatments of blood cancers.
Blood Cancer 101: What You Need to Know
UCLA oncologists Gary Schiller, MD and Patricia Young, MD, and social worker Rebecca Pittenger, LCSW, give an overview of blood cancers, what causes them, symptoms and diagnosis. Our specialists cover the latest treatment options and clinical trials available to patients in a conversation moderated by Leila Evangelista from the Leukemia & Lymphoma Society.